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Background
Hypertrophic cardiomyopathy (HCM) is characterised by
reduced myocardial tissue oxygenation (assessed using
blood oxygen level dependent (BOLD) CMR imaging) dur-
ing stress, as well as reduced myocardial perfusion reserve
(MPRI) due to coronary microvascular dysfunction. In
HCM gene carriers without the HCM phenotype, it has
been suggested that only oxygenation is impaired. [1] It
remains unclear whether this relates to early cardiac remo-
delling/ diastolic dysfunction, or whether oxygen con-
sumption is intrinsically altered with sarcomere mutations.
We sought to assess the BOLD signal change during vaso-
dilator stress in a homogenous group of MYPBC3 positive
HCM patients (some with clinical HCM, and some with
no phenotypic features of HCM), and normal controls.
Methods
A total of 21 subjects with MYPBC3 mutations (11 with
(G+P+) and 10 without (G+P-) phenotypic evidence of
HCM on MRI or echocardiogram), and 6 normal con-
trols underwent CMR scanning at 3.0 T. Myocardial
function, as well as oxygenation (BOLD signal intensity
change) during rest and adenosine stress was performed.
All HCM (both G+ P+ and G+P-) patients had trans-
thoracic echocardiography performed, including evalua-
tion of diastolic function using pulsed-wave and tissue
Doppler.
Results
Mean age (yrs) was similar across the groups (40 for G+P+,
39.5 for G+P- and 45 for normal controls). Maximal septal
thickness was 21mm in the G+P+ group, vs 9.2 for the
G+P- group. As expected, the G+P+ group had a blunted
oxygenation response during stress (BOLD SI change
-4.8 ± 10.3% vs controls 11.1 ± 8.1, p= 0.003). The G+P-
group also showed reduced oxygen response during stress
(BOLD SI change 2.5 ± 4.8% vs controls, p= 0.009). 8 of
the 11 (73%) G+P+ HCM patients had diastolic dysfunc-
tion, vs none of the G+P- group. Mean E/E’ was 13.3 ± 2.8
for the G+P+ group vs 8 ± 1.9 for the G+P- group,
p = <.00001.
Conclusions
HCM gene carriers without hypertrophy show reduced
myocardial oxygenation during vasodilator stress com-
pared to normal controls. Our findings support the
hypothesis that alterations in cardiac energetics may be
due to the presence of sarcomere mutations rather than
cardiac remodelling or diastolic dysfunction which occur
at a later stage.
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